Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ocular Therapeutix Inc (NASDAQ:OCUL)

10.64
Delayed Data
As of May 04
 -1.06 / -9.06%
Today’s Change
5.07
Today|||52-Week Range
29.22
+13.55%
Year-to-Date
No recent news for Ocular Therapeutix Inc.

Today’s Trading

Previous close11.70
Today’s open11.62
Day’s range10.55 - 11.75
Volume225,776
Average volume (3 months)293,513
Market cap$294.6M
Dividend yield--
Data as of 4:00pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)+36.43%
Earnings growth (this year)-6.63%
Earnings growth (next 5 years)+43.00%
Revenue growth (last year)+126.68%
P/E ratioNM
Price/Sales124.46
Price/Book3.29

Competitors

 Today’s
change
Today’s
% change
LMATLeMaitre Vascular In...-0.25-1.53%
--Nemaura Medical Inc0.000.00%
TNDMTandem Diabetes Care...-0.45-5.44%
SRDXSurModics Inc-0.84-3.64%
Data as of 4:00pm ET, 05/04/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$1.8M
Annual profit (last year)-$39.7M
Net profit margin-2,271.31%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Amarpreet S. Sawhney
Chief Operating Officer
James Fortune
Corporate headquarters
Bedford, Massachusetts

Forecasts

Partner Offers

Search for Jobs